Disseminated infection with Mycobacterium genavense: a challenge to physicians and mycobacteriologists.
In the present study we compared the clinical presentations of patients with a clinical diagnosis of AIDS and disseminated Mycobacterium genavense infection (n = 12) with those of patients with AIDS and disseminated M. avium complex (MAC) infection (n = 24). Abdominal pain was seen more frequently in the group of patients infected with M. genavense than in patients infected with MAC (P = 0. 003). Analysis of microbiological data revealed that stool specimens from patients infected with M. genavense were more often smear positive than stool specimens from patients infected with MAC (P = 0. 00002). However, M. genavense could be cultured on solid media from only 15.4% of the stool specimens, whereas MAC could be cultured from 71.4% of the specimens. Bone marrow and liver biopsy specimens yielded growth of M. genavense within a reasonably short time, allowing species identification by DNA technology. Microbiological data clearly demonstrated the importance of acidic liquid medium for primary culture, the avoidance of pretreatment and the use of additives in culture, and the necessity for prolonged incubation if M. genavense is suspected. Susceptibility testing showed that M. genavense is sensitive to rifamycins, fluoroquinolones, and macrolides, whereas it is resistant to isoniazid. Susceptibility to ethambutol and clofazimine could not be evaluated. The mean survival times of patients in the two groups were similar.
Thomsen
V O
VO
Department of Mycobacteriology, Statens Serum Institut, Copenhagen, Denmark. vot@ssi.dk
Dragsted
U B
UB
Bauer
J
J
Fuursted
K
K
Lundgren
J
J
D017088:AIDS-Related Opportunistic Infections / Q000382:microbiology* / Q000503:physiopathology; D000328:Adult; D000995:Antitubercular Agents / Q000494:pharmacology; D003470:Culture Media; D005260:Female; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008297:Male; D008826:Microbial Sensitivity Tests; D009161:Mycobacterium / Q000145:classification / Q000187:drug effects / Q000302:isolation & purification*; D009164:Mycobacterium Infections / Q000382:microbiology* / Q000503:physiopathology; D015269:Mycobacterium avium Complex / Q000302:isolation & purification; D015270:Mycobacterium avium-intracellulare Infection / Q000382:microbiology / Q000503:physiopathology; D013048:Specimen Handling
D000995:Antitubercular Agents; D003470:Culture Media